PROTOONCOGENE EXPRESSION IN DIFFERENTIATING AND NONDIFFERENTIATING CHRONIC MYELOGENOUS LEUKEMIA-CELLS

被引:6
作者
WANG, Z
YIN, MY
XIE, XX
YANG, PM
SATO, H
MAYERS, G
RIOBOWAL, C
PREISLER, HD
机构
[1] BARRETT CTR CANC PREVENT TREATMENT & RES,234 GOODMAN ST,CINCINNATI,OH 45267
[2] UNIV CINCINNATI,MED CTR,CINCINNATI,OH 45267
[3] KANTO TEISHIN HOSP,SHINAGAWA KU,TOKYO 141,JAPAN
[4] PK MEM INST,BUFFALO,NY
关键词
D O I
10.1016/0277-5379(90)90119-E
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the profound differences between the chronic and blastic phases of chronic myelogenous leukaemia, no differences between chronic and blastic phase cells have been described at the molecular level. Differences have been found in the levels of expression of c-myc, c-myb and p53, which fell when chronic phase cells were cultured, while the levels of expression of the genes were stable when blastic crisis cells were cultured. In contrast c-fms expression increased and MRS expression decreased after culture of chronic or blastic phase cells. The data suggest that the regulation of expression of some genes in blastic crisis cells is unaltered while that of others is disrupted. It is not known whether the failure of c-myc, c-myb and p53 expression to fall during the culture of blastic phase cells is the cause of or a reflection of the failure of these cells to differentiate. © 1990.
引用
收藏
页码:694 / 698
页数:5
相关论文
共 50 条
  • [41] Stem cells in chronic myelogenous leukemia
    Verfaillie, CM
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (06) : 1079 - +
  • [42] EXPRESSION OF HLA ANTIGENS ON LEUKEMIA-CELLS
    MAYER, S
    TONGIO, MM
    FALKENRODT, A
    PFEIFFER, B
    BERGERAT, JP
    JOURNAL OF IMMUNOGENETICS, 1982, 9 (02): : 111 - 120
  • [43] ASSOCIATION OF PI 3-KINASE WITH PROTEINS OF RAS SIGNALING PATHWAY IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS
    HARRISONFINDIK, D
    SUSA, M
    VARTICOVSKI, L
    FASEB JOURNAL, 1994, 8 (07) : A1446 - A1446
  • [44] BCR-ABL MAINTAINS RESISTANCE OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS TO APOPTOTIC CELL-DEATH
    MCGAHON, A
    BISSONNETTE, R
    SCHMITT, M
    COTTER, KM
    GREEN, DR
    COTTER, TG
    BLOOD, 1994, 83 (05) : 1179 - 1187
  • [45] RESIDUAL JUVENILE CHRONIC MYELOGENOUS LEUKEMIA-CELLS DETECTED IN PERIPHERAL-BLOOD DURING CLINICAL REMISSION
    ESTROV, Z
    DUBE, ID
    CHAN, HSL
    FREEDMAN, MH
    BLOOD, 1987, 70 (05) : 1466 - 1469
  • [46] A MURINE MONOCLONAL-ANTIBODY RECOGNIZING HUMAN MYELOGENOUS LEUKEMIA-CELLS
    NEWTON, IA
    BERTHIER, R
    MOUCHIROUD, G
    HOLLARD, D
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 360 - 360
  • [47] DIFFERENTIATION INVITRO OF HUMAN MYELOGENOUS LEUKEMIA-CELLS FROM PATIENTS IN RELAPSE
    HONMA, Y
    FUJITA, Y
    KASUKABE, T
    HOZUMI, M
    SAMPI, K
    SAKURAI, M
    TSUSHIMA, S
    NOMURA, H
    GANN, 1984, 75 (06): : 518 - 524
  • [48] INDUCTION OF DIFFERENTIATION OF HUMAN ACUTE MYELOGENOUS LEUKEMIA-CELLS - THERAPEUTIC IMPLICATIONS
    KOEFFLER, HP
    BLOOD, 1983, 62 (04) : 709 - 721
  • [49] AUTOSTIMULATION OF GROWTH BY HUMAN MYELOGENOUS LEUKEMIA-CELLS (HL-60)
    BRENNAN, JK
    ABBOUD, CN
    DIPERSIO, JF
    BARLOW, GH
    LICHTMAN, MA
    BLOOD, 1981, 58 (04) : 803 - 812
  • [50] Significance of FHIT expression in chronic myelogenous leukemia
    Kantarjian, HM
    Talpaz, M
    O'Brien, S
    Manshouri, T
    Cortes, J
    Giles, F
    Rios, MB
    Croce, CM
    Albitar, M
    CLINICAL CANCER RESEARCH, 1999, 5 (12) : 4059 - 4064